EA201000738A1 - Медицинское применение 3-(2,2,2-триметилгидразиниум)пропионат гидрофумарата и дигидрофосфата - Google Patents

Медицинское применение 3-(2,2,2-триметилгидразиниум)пропионат гидрофумарата и дигидрофосфата

Info

Publication number
EA201000738A1
EA201000738A1 EA201000738A EA201000738A EA201000738A1 EA 201000738 A1 EA201000738 A1 EA 201000738A1 EA 201000738 A EA201000738 A EA 201000738A EA 201000738 A EA201000738 A EA 201000738A EA 201000738 A1 EA201000738 A1 EA 201000738A1
Authority
EA
Eurasian Patent Office
Prior art keywords
propionate
trimethylgydrazinium
gydrofumate
digitrophosphate
medical indication
Prior art date
Application number
EA201000738A
Other languages
English (en)
Other versions
EA019424B1 (ru
Inventor
Илмарс Стонанс
Эдуард Тарарак
Елена Андреева
Original Assignee
Гриндекс, Джоинт Сток Кампани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40481525&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201000738(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Гриндекс, Джоинт Сток Кампани filed Critical Гриндекс, Джоинт Сток Кампани
Publication of EA201000738A1 publication Critical patent/EA201000738A1/ru
Publication of EA019424B1 publication Critical patent/EA019424B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Изобретение относится к новому медицинскому применению 3-(2,2,2-триметилгидразиниум)пропионата для приготовления лекарственного средства для предотвращения и лечения атеросклероза.
EA201000738A 2007-12-04 2008-12-03 Медицинское применение 3-(2,2,2-триметилгидразиниум)пропионат гидрофумарата и дигидрофосфата EA019424B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07122272 2007-12-04
EP07122273 2007-12-04
PCT/EP2008/066711 WO2009071585A1 (en) 2007-12-04 2008-12-03 Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate and dihydrogen phosphate

Publications (2)

Publication Number Publication Date
EA201000738A1 true EA201000738A1 (ru) 2011-04-29
EA019424B1 EA019424B1 (ru) 2014-03-31

Family

ID=40481525

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201000738A EA019424B1 (ru) 2007-12-04 2008-12-03 Медицинское применение 3-(2,2,2-триметилгидразиниум)пропионат гидрофумарата и дигидрофосфата

Country Status (32)

Country Link
US (1) US20100234459A1 (ru)
EP (1) EP2222293B1 (ru)
JP (1) JP2011505408A (ru)
KR (1) KR20100084688A (ru)
CN (1) CN101951898B (ru)
AR (1) AR069521A1 (ru)
AT (1) ATE518536T1 (ru)
AU (1) AU2008333262A1 (ru)
BR (1) BRPI0819057A2 (ru)
CA (1) CA2706354C (ru)
CL (1) CL2008003551A1 (ru)
CO (1) CO6280477A2 (ru)
CY (1) CY1112336T1 (ru)
DK (1) DK2222293T3 (ru)
DO (1) DOP2010000163A (ru)
EA (1) EA019424B1 (ru)
GE (1) GEP20125673B (ru)
HR (1) HRP20110744T1 (ru)
IL (1) IL205961A0 (ru)
MA (1) MA31993B1 (ru)
MX (1) MX2010006255A (ru)
MY (1) MY150508A (ru)
PA (1) PA8805901A1 (ru)
PE (1) PE20091037A1 (ru)
PL (1) PL2222293T3 (ru)
PT (1) PT2222293E (ru)
RS (1) RS51992B (ru)
SI (1) SI2222293T1 (ru)
TN (1) TN2010000250A1 (ru)
TW (1) TW200930356A (ru)
WO (1) WO2009071585A1 (ru)
ZA (1) ZA201003641B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2425835A1 (en) * 2010-08-18 2012-03-07 Grindeks, a joint stock company A new medical use of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate and natural flavonoid derivatives
TWI487524B (zh) * 2010-12-03 2015-06-11 Tetra Sia 菸鹼酸和米曲肼之新穎治療組合

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA009083B1 (ru) * 2003-08-04 2007-10-26 Акционерное Общество "Гриндекс" Соли мелдония, способ их получения и фармацевтические композиции на их основе

Also Published As

Publication number Publication date
GEP20125673B (en) 2012-10-25
RS51992B (en) 2012-04-30
CL2008003551A1 (es) 2010-01-22
AU2008333262A1 (en) 2009-06-11
EA019424B1 (ru) 2014-03-31
EP2222293A1 (en) 2010-09-01
BRPI0819057A2 (pt) 2015-05-05
PL2222293T3 (pl) 2012-01-31
CA2706354A1 (en) 2009-06-11
CY1112336T1 (el) 2015-12-09
ATE518536T1 (de) 2011-08-15
TW200930356A (en) 2009-07-16
US20100234459A1 (en) 2010-09-16
TN2010000250A1 (en) 2011-11-11
MA31993B1 (fr) 2011-01-03
AR069521A1 (es) 2010-01-27
PE20091037A1 (es) 2009-08-19
CO6280477A2 (es) 2011-05-20
JP2011505408A (ja) 2011-02-24
MY150508A (en) 2014-01-30
PT2222293E (pt) 2011-11-15
MX2010006255A (es) 2011-03-15
HRP20110744T1 (hr) 2011-11-30
IL205961A0 (en) 2010-11-30
CA2706354C (en) 2013-08-13
ZA201003641B (en) 2011-03-30
CN101951898B (zh) 2012-12-05
DOP2010000163A (es) 2010-08-31
DK2222293T3 (da) 2011-11-21
WO2009071585A1 (en) 2009-06-11
KR20100084688A (ko) 2010-07-27
SI2222293T1 (sl) 2011-12-30
CN101951898A (zh) 2011-01-19
EP2222293B1 (en) 2011-08-03
PA8805901A1 (es) 2009-07-23

Similar Documents

Publication Publication Date Title
ATE534378T1 (de) Titrierung von tapentadol
ME02414B (me) Tretman kronove bolesti lakvinimodom
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
LTC1781298I2 (lt) Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui
EA201690265A2 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
CL2009000349A1 (es) Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer.
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
MY151048A (en) Use of flibanserin for the treatment of post-menopausal sexual desire disorders
EA200901423A1 (ru) Бензимидазолы и содержащие их фармацевтические композиции
TW200738699A (en) 4-Substituted pyrazoline compounds, their preparation and use as medicaments
MA32841B1 (fr) Composés de cycloundeca depsipeptides et leur utilisation comme médicament
MX2009010374A (es) Derivados de tetrahidro-naftalenamina sustituidos con heterociclilo, su preparacion y su uso como medicamentos.
BR112012007888A2 (pt) "métodos de tratamento usando anticorpos anti-ldl oxidada".
CY1114760T1 (el) Θεραπευτικη αγωγη αθηροσκληρωσης
NO20076405L (no) Anvendelse av 24-nor-UDCA
TW200745042A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
EA201000738A1 (ru) Медицинское применение 3-(2,2,2-триметилгидразиниум)пропионат гидрофумарата и дигидрофосфата
WO2009074498A8 (en) Medical use of 3- (2, 2, 2-trimethylhydrazinixm) propionate orotate
EA200970969A1 (ru) Применение 4-циклопропилметокси-n-(3,5-дихлор-1-оксидопиридин-4-ил)-5-(метокси)пиридин-2-карбоксамида для лечения травм спинного мозга
EA201000739A1 (ru) Новое медицинское применение солей 3-(2,2,2-триметилгидразиниум)пропионата
EA200801890A1 (ru) Средство для лечения шума в ушах
MX2009012761A (es) Neramexano para el tratamiento de nistagmo.
UA99093C2 (ru) Применение фенофибрата или его производного для лечения диабетической ретинопатии
MY150436A (en) 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU